- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04914156
The Use of Nutrigenomics in Sports Nutrition
September 27, 2021 updated by: Dr Andrea Braakhuis, University of Auckland, New Zealand
The study's aim is to determine if nutrigenomics-based dietary advice is a greater motivator for dietary change amongst an athlete population.
Specifically, the investigators will be examining whether nutrigenomics-based personalized dietary advice results in greater changes in dietary intake and body composition amongst athletes compared to personalised population-based sports nutrition advice.
It is hypothesized that the Nutrigenomics in Sports Nutrition group would engage in greater dietary changes and better adhere to the dietary advice compared to the standard advice group.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Auckland, New Zealand
- University of Auckland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older
- Competes in representative sports team
- Has access to the internet and smart phone device
- Able to speak English
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Personalised, genetic-based advice for sport performance
This group will receive personalised nutrition advice for sports performance based on their genetic test results and tailored to their current dietary intake.
|
Genetic test results for 70 genes relating to nutrition and physical activity will be used in conjunction with participants current dietary intake to create nutrition advice tailored to each individual.
|
|
Active Comparator: Personalised nutrition advice for sport performance based on population-based evidence
This group will receive personalised nutrition advice on key nutrients relating to sports performance based on current best practice, population-based sport nutrition guidelines.
These will be tailored to their current dietary intake
|
Current dietary intake will be compared with current best practice population-based sports nutrition dietary advice to create tailored nutrition advice for each of the participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in dietary intake from baseline
Time Frame: 8 weeks
|
We will assess dietary intake for energy intake, carbohydrates, protein, fat, sodium, caffeine, glycemic index, iron, Vitamin A, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, Folate and Calcium using a 3 day food record conducted at baseline using Easy Diet Diary phone application.
A second 3 day food record will be conducted post intervention period to examine any changes in dietary habits.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in body composition from baseline
Time Frame: 8 weeks
|
At baseline, participants will indicate body composition goals and baseline body composition measurements will be taken using International Society for Advancement of Kinanthropometry accredited guidelines.
Repeated body composition measurements will be taken post intervention to examine in any changes in body composition.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 4, 2021
Primary Completion (Anticipated)
September 1, 2022
Study Completion (Anticipated)
September 1, 2024
Study Registration Dates
First Submitted
May 30, 2021
First Submitted That Met QC Criteria
May 30, 2021
First Posted (Actual)
June 4, 2021
Study Record Updates
Last Update Posted (Actual)
September 29, 2021
Last Update Submitted That Met QC Criteria
September 27, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 5000928
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.